Unknown OBSERVATIONAL NCT05730114

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients (PLT-ECMO)

Platelet Aggregation in Patients Treated With P2Y12 Inhibitors and V-A ECMO for Cardiac Arrest

Sponsor: University of Milano Bicocca

Conditions Cardiac Arrest Extracorporeal Membrane Oxygenation Myocardial Infarction Platelet Dysfunction

Updated 4 times since 2023 Last updated: Feb 14, 2023 Started: Oct 1, 2022 Primary completion: Sep 30, 2024 Completion: Oct 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiac Arrest and Extracorporeal Membrane Oxygenation and is currently ongoing. University of Milano Bicocca leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Milano Bicocca

Data source: University of Milano Bicocca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monza, Italy